The Pharmaceutical Industry — Prices and Progress
- 26 August 2004
- journal article
- editorial
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 351 (9) , 927-932
- https://doi.org/10.1056/nejmhpr040117
Abstract
In this Health Policy Report, the author examines the economics of the pharmaceutical industry. Research-and-development costs, patent laws, and health insurance coverage all influence drug pricing. The author discusses the policy dilemmas resulting from the complex economics of pharmaceutical research and development and reviews potential strategies to control prices.This publication has 3 references indexed in Scilit:
- International Differences in Drug PricesAnnual Review of Public Health, 2004
- The price of innovation: new estimates of drug development costsJournal of Health Economics, 2003
- Technology policy for a world of skew-distributed outcomesResearch Policy, 2000